Determining pathogenicity of genetic variants Flashcards

1
Q

What is a pathogenic variant

A

It is a genetic alteration that increases an individuals susceptibility or predisposition to a certain disease or disorder. When such a variant is inherited, development of symptoms is more likely, but not certain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pathogenicity ?

A

It is much more complex

All three overlap to cause disease
- genetic change
- environment
- epidemics

Can be:
Polygenic
Monogenic
Mitochondrial
Chromosomal

Alter gene function
- promoter function
- splicing
- intronic

Alter protein function
- alter formation of the protein
- alter structure of protein
- protein aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is it important to determine pathogenicity ?

A

Prognosis
- which gene is affected determines prognosis and monitoring for the disease

Treatment
- determined treatment and possible genetic therapies in the future

Inheritance
- determines inheritance pattern and genetic counselling

Searching for a diagnosis
- If not pathogenic need to keep looking for the underlying causative variant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How we determine pathogenicity

A

Some key elements:
- patient phenotype
- gene
- type of variant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patient phenotype

A

Careful assessment of the patient for the main clinical features
- do they fit a known clinical pattern?

Inheritance
- are other family members affected? Are they alive?
- what is the pattern?

Key clinical signs
- skeletal dysmorphisms

Consider blood tests, imaging and biopsy of affected tissue

  1. Which gene? Single gene analysis, gene panel analysis, next generation sequencing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Understanding the gene

A

Are variants in the gene already known to cause this disease?

Is the gene associated with similar diseases?

What is the function of the protein?

Is the gene expressed in the affected tissues?

  1. Is it a known variant
  2. Where in the gene is it (intronic, exonic)
  3. What type of variant is it
  4. Is it in a highly conserved region
  5. How often is it seen in the population
  6. Where in the protein is it
  7. Does it segregate in the family
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Population data

A

Is the variant present in a frequency > than known prevalence?
(More likely to be pathogenic)

Has it been reported by other groups in affected patients?

If present in a frequency >5%
(Very likely to be benign)

  1. Control data can contain affected individuals
  2. Disease variants are not always validated
  3. Some recessive variants have high rates
  4. Need ethically- matched controls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Computational data

A

In silico tools to predict if a change is likely to affect the gene/transcript/ protein.

Look at - missense variants:
- polyPhen2
- SIFT
- Mutation taster

Splicing:
- gene splicer
- human splicing finder

Takes into account
- types of change
- evolutionary conservation of the region
- location of variant in the gene
- effect on structure of protein
- Seen in other databases ? ClinVar, bSNP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Computational data
A

Type of change
- certain variants are more likely to be pathogenic if the mechanism is loss of function
(Nonsense, frameshift, deletions)

  • some are more likely to be benign
    (Synonymous (silent) - does not change protein code) rarely can be pathogenic if it affects splice site

Type of change:
- missense variants
(Has there been a change in the properties of the amino acid?)- acidic -> basic
Polar -> non-polar

Evolutionary conservation
- is it in a highly conserved region through species ?
- highly conserved regions are less able to tolerate changes in genetic code

Location of variant in gene
- is it in a key subunit binding region/ pore forming region?
- effect on structure of protein
(Alter folding of protein?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Segregation of data

A

Clear segregation of variant in other affected family members/ not in unaffected members

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

De novo data

A

De novo variants are more likely to be pathogenic
- variant occurs in the germline
- parents not carriers
- paternity known
- this is more common in some disease
(Associated with older paternal age)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Allelic data

A

If recessive - need to check variants are in trans

Paternal testing can confirm this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Functional studies

A

Extremely valuable in determining pathogenicity
Especially useful in:
- channelopathies
- enzyme function
- mRNA levels - for splicing variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly